16-1208033-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021098.3(CACNA1H):​c.3175G>T​(p.Ala1059Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00933 in 1,606,222 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A1059A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0071 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0096 ( 94 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

3
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.90

Publications

10 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007585913).
BP6
Variant 16-1208033-G-T is Benign according to our data. Variant chr16-1208033-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 460081.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00705 (1073/152182) while in subpopulation AMR AF = 0.0112 (172/15292). AF 95% confidence interval is 0.00987. There are 7 homozygotes in GnomAd4. There are 495 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1073 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 35 ENST00000348261.11 NP_066921.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 35 1 NM_021098.3 ENSP00000334198.7
CACNA1HENST00000569107.6 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 34 1 ENSP00000454990.2
CACNA1HENST00000711493.1 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 34 1 ENSP00000455840.1
CACNA1HENST00000711450.1 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 35 1 ENSP00000457555.2
CACNA1HENST00000638323.1 linkc.3136G>T p.Ala1046Ser missense_variant Exon 16 of 35 5 ENSP00000492267.1
CACNA1HENST00000562079.6 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 34 1 ENSP00000454581.2
CACNA1HENST00000711438.1 linkc.3136G>T p.Ala1046Ser missense_variant Exon 16 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.3175G>T p.Ala1059Ser missense_variant Exon 16 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 34 5 ENSP00000492650.2
CACNA1HENST00000639478.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 35 5 ENSP00000491945.1
CACNA1HENST00000640028.1 linkn.*1088G>T non_coding_transcript_exon_variant Exon 16 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*2622G>T non_coding_transcript_exon_variant Exon 15 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.3175G>T non_coding_transcript_exon_variant Exon 16 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*1088G>T 3_prime_UTR_variant Exon 16 of 35 5 ENSP00000491488.1
CACNA1HENST00000711442.1 linkn.*2622G>T 3_prime_UTR_variant Exon 15 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.00707
AC:
1075
AN:
152064
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00210
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0113
Gnomad ASJ
AF:
0.0208
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00373
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0100
Gnomad OTH
AF:
0.00861
GnomAD2 exomes
AF:
0.00725
AC:
1707
AN:
235422
AF XY:
0.00757
show subpopulations
Gnomad AFR exome
AF:
0.00206
Gnomad AMR exome
AF:
0.00636
Gnomad ASJ exome
AF:
0.0172
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00102
Gnomad NFE exome
AF:
0.0102
Gnomad OTH exome
AF:
0.0123
GnomAD4 exome
AF:
0.00957
AC:
13920
AN:
1454040
Hom.:
94
Cov.:
33
AF XY:
0.00945
AC XY:
6827
AN XY:
722570
show subpopulations
African (AFR)
AF:
0.00294
AC:
98
AN:
33340
American (AMR)
AF:
0.00660
AC:
290
AN:
43966
Ashkenazi Jewish (ASJ)
AF:
0.0157
AC:
409
AN:
25982
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39346
South Asian (SAS)
AF:
0.00394
AC:
334
AN:
84676
European-Finnish (FIN)
AF:
0.000928
AC:
48
AN:
51744
Middle Eastern (MID)
AF:
0.0398
AC:
225
AN:
5652
European-Non Finnish (NFE)
AF:
0.0107
AC:
11861
AN:
1109220
Other (OTH)
AF:
0.0109
AC:
654
AN:
60114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
718
1435
2153
2870
3588
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00705
AC:
1073
AN:
152182
Hom.:
7
Cov.:
32
AF XY:
0.00665
AC XY:
495
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.00207
AC:
86
AN:
41500
American (AMR)
AF:
0.0112
AC:
172
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0208
AC:
72
AN:
3466
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.00373
AC:
18
AN:
4824
European-Finnish (FIN)
AF:
0.000942
AC:
10
AN:
10620
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0100
AC:
682
AN:
67998
Other (OTH)
AF:
0.00852
AC:
18
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00923
Hom.:
6
Bravo
AF:
0.00753
TwinsUK
AF:
0.0146
AC:
54
ALSPAC
AF:
0.0112
AC:
43
ESP6500AA
AF:
0.00247
AC:
10
ESP6500EA
AF:
0.0100
AC:
83
ExAC
AF:
0.00649
AC:
783
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Jun 03, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 17696120, 25525159, 26706850)

Jun 06, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CACNA1H: BS1, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
20
DANN
Benign
0.75
DEOGEN2
Benign
0.11
T;.;.;.
Eigen
Benign
-0.042
Eigen_PC
Benign
-0.067
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.76
T;T;T;.
MetaRNN
Benign
0.0076
T;T;T;T
MetaSVM
Uncertain
-0.053
T
MutationAssessor
Benign
1.8
L;.;L;L
PhyloP100
4.9
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.0
N;.;N;N
REVEL
Uncertain
0.31
Sift
Benign
0.56
T;.;T;T
Sift4G
Benign
0.66
T;.;T;T
Vest4
0.47
ClinPred
0.022
T
GERP RS
3.0
Varity_R
0.081
gMVP
0.38
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41292285; hg19: chr16-1258033; COSMIC: COSV61998622; COSMIC: COSV61998622; API